Avacta Group Company
We develop safe and efficacious drugs, and powerful research and diagnostic tools, based on our proprietary Affimer and pre|CISION platforms
Employee Number:
11-50
Funding Status:
IPO
Headquarters:
Wetherby, York, United Kingdom
Technology:
Cancer
Estimated Revenue:
$1M to $10M
Founded Date:
2003
Industry:
PharmTech